Combined genetic deletion of GDF15 and FGF21 has modest effects on body weight, hepatic steatosis and insulin resistance in high fat fed mice

Objectives: Obesity in humans and mice is associated with elevated levels of two hormones responsive to cellular stress, namely GDF15 and FGF21. Over-expression of each of these is associated with weight loss and beneficial metabolic changes but where they are secreted from and what they are require...

Full description

Bibliographic Details
Main Authors: Satish Patel, Afreen Haider, Anna Alvarez-Guaita, Guillaume Bidault, Julia Sarah El-Sayed Moustafa, Esther Guiu-Jurado, John A. Tadross, James Warner, James Harrison, Samuel Virtue, Fabio Scurria, Ilona Zvetkova, Matthias Blüher, Kerrin S. Small, Stephen O’Rahilly, David B. Savage
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:Molecular Metabolism
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2212877822001582
_version_ 1828107456125861888
author Satish Patel
Afreen Haider
Anna Alvarez-Guaita
Guillaume Bidault
Julia Sarah El-Sayed Moustafa
Esther Guiu-Jurado
John A. Tadross
James Warner
James Harrison
Samuel Virtue
Fabio Scurria
Ilona Zvetkova
Matthias Blüher
Kerrin S. Small
Stephen O’Rahilly
David B. Savage
author_facet Satish Patel
Afreen Haider
Anna Alvarez-Guaita
Guillaume Bidault
Julia Sarah El-Sayed Moustafa
Esther Guiu-Jurado
John A. Tadross
James Warner
James Harrison
Samuel Virtue
Fabio Scurria
Ilona Zvetkova
Matthias Blüher
Kerrin S. Small
Stephen O’Rahilly
David B. Savage
author_sort Satish Patel
collection DOAJ
description Objectives: Obesity in humans and mice is associated with elevated levels of two hormones responsive to cellular stress, namely GDF15 and FGF21. Over-expression of each of these is associated with weight loss and beneficial metabolic changes but where they are secreted from and what they are required for physiologically in the context of overfeeding remains unclear. Methods: Here we used tissue selective knockout mouse models and human transcriptomics to determine the source of circulating GDF15 in obesity. We then generated and characterized the metabolic phenotypes of GDF15/FGF21 double knockout mice. Results: Circulating GDF15 and FGF21 are both largely derived from the liver, rather than adipose tissue or skeletal muscle, in obese states. Combined whole body deletion of FGF21 and GDF15 does not result in any additional weight gain in response to high fat feeding but it does result in significantly greater hepatic steatosis and insulin resistance than that seen in GDF15 single knockout mice. Conclusions: Collectively the data suggest that overfeeding activates a stress response in the liver which is the major source of systemic rises in GDF15 and FGF21. These hormones then activate pathways which reduce this metabolic stress.
first_indexed 2024-04-11T10:31:22Z
format Article
id doaj.art-86d575de029d49f1be5d61f2c525a70f
institution Directory Open Access Journal
issn 2212-8778
language English
last_indexed 2024-04-11T10:31:22Z
publishDate 2022-11-01
publisher Elsevier
record_format Article
series Molecular Metabolism
spelling doaj.art-86d575de029d49f1be5d61f2c525a70f2022-12-22T04:29:24ZengElsevierMolecular Metabolism2212-87782022-11-0165101589Combined genetic deletion of GDF15 and FGF21 has modest effects on body weight, hepatic steatosis and insulin resistance in high fat fed miceSatish Patel0Afreen Haider1Anna Alvarez-Guaita2Guillaume Bidault3Julia Sarah El-Sayed Moustafa4Esther Guiu-Jurado5John A. Tadross6James Warner7James Harrison8Samuel Virtue9Fabio Scurria10Ilona Zvetkova11Matthias Blüher12Kerrin S. Small13Stephen O’Rahilly14David B. Savage15University of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, CB2 0QQ, UK; MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK; Corresponding author.University of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, CB2 0QQ, UK; MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK; Corresponding author.University of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, CB2 0QQ, UKUniversity of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, CB2 0QQ, UKDepartment of Twin Research and Genetic Epidemiology, King’s College London, St Thomas’ Campus, London, SE1 7EH, UKMedical Department III – Endocrinology, Nephrology, Rheumatology, University of Leipzig Medical Center, 04103 Leipzig, GermanyUniversity of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, CB2 0QQ, UK; East Midlands and East of England Genomic Laboratory Hub & Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UKUniversity of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, CB2 0QQ, UKDepartment of Medicine, Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UKUniversity of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, CB2 0QQ, UKUniversity of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, CB2 0QQ, UKUniversity of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, CB2 0QQ, UKMedical Department III – Endocrinology, Nephrology, Rheumatology, University of Leipzig Medical Center, 04103 Leipzig, Germany; Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München, University of Leipzig and University Hospital Leipzig, Leipzig, GermanyDepartment of Twin Research and Genetic Epidemiology, King’s College London, St Thomas’ Campus, London, SE1 7EH, UKUniversity of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, CB2 0QQ, UK; MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UKUniversity of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, CB2 0QQ, UK; MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK; Corresponding author.Objectives: Obesity in humans and mice is associated with elevated levels of two hormones responsive to cellular stress, namely GDF15 and FGF21. Over-expression of each of these is associated with weight loss and beneficial metabolic changes but where they are secreted from and what they are required for physiologically in the context of overfeeding remains unclear. Methods: Here we used tissue selective knockout mouse models and human transcriptomics to determine the source of circulating GDF15 in obesity. We then generated and characterized the metabolic phenotypes of GDF15/FGF21 double knockout mice. Results: Circulating GDF15 and FGF21 are both largely derived from the liver, rather than adipose tissue or skeletal muscle, in obese states. Combined whole body deletion of FGF21 and GDF15 does not result in any additional weight gain in response to high fat feeding but it does result in significantly greater hepatic steatosis and insulin resistance than that seen in GDF15 single knockout mice. Conclusions: Collectively the data suggest that overfeeding activates a stress response in the liver which is the major source of systemic rises in GDF15 and FGF21. These hormones then activate pathways which reduce this metabolic stress.http://www.sciencedirect.com/science/article/pii/S2212877822001582GDF15FGF21Insulin resistanceObesity
spellingShingle Satish Patel
Afreen Haider
Anna Alvarez-Guaita
Guillaume Bidault
Julia Sarah El-Sayed Moustafa
Esther Guiu-Jurado
John A. Tadross
James Warner
James Harrison
Samuel Virtue
Fabio Scurria
Ilona Zvetkova
Matthias Blüher
Kerrin S. Small
Stephen O’Rahilly
David B. Savage
Combined genetic deletion of GDF15 and FGF21 has modest effects on body weight, hepatic steatosis and insulin resistance in high fat fed mice
Molecular Metabolism
GDF15
FGF21
Insulin resistance
Obesity
title Combined genetic deletion of GDF15 and FGF21 has modest effects on body weight, hepatic steatosis and insulin resistance in high fat fed mice
title_full Combined genetic deletion of GDF15 and FGF21 has modest effects on body weight, hepatic steatosis and insulin resistance in high fat fed mice
title_fullStr Combined genetic deletion of GDF15 and FGF21 has modest effects on body weight, hepatic steatosis and insulin resistance in high fat fed mice
title_full_unstemmed Combined genetic deletion of GDF15 and FGF21 has modest effects on body weight, hepatic steatosis and insulin resistance in high fat fed mice
title_short Combined genetic deletion of GDF15 and FGF21 has modest effects on body weight, hepatic steatosis and insulin resistance in high fat fed mice
title_sort combined genetic deletion of gdf15 and fgf21 has modest effects on body weight hepatic steatosis and insulin resistance in high fat fed mice
topic GDF15
FGF21
Insulin resistance
Obesity
url http://www.sciencedirect.com/science/article/pii/S2212877822001582
work_keys_str_mv AT satishpatel combinedgeneticdeletionofgdf15andfgf21hasmodesteffectsonbodyweighthepaticsteatosisandinsulinresistanceinhighfatfedmice
AT afreenhaider combinedgeneticdeletionofgdf15andfgf21hasmodesteffectsonbodyweighthepaticsteatosisandinsulinresistanceinhighfatfedmice
AT annaalvarezguaita combinedgeneticdeletionofgdf15andfgf21hasmodesteffectsonbodyweighthepaticsteatosisandinsulinresistanceinhighfatfedmice
AT guillaumebidault combinedgeneticdeletionofgdf15andfgf21hasmodesteffectsonbodyweighthepaticsteatosisandinsulinresistanceinhighfatfedmice
AT juliasarahelsayedmoustafa combinedgeneticdeletionofgdf15andfgf21hasmodesteffectsonbodyweighthepaticsteatosisandinsulinresistanceinhighfatfedmice
AT estherguiujurado combinedgeneticdeletionofgdf15andfgf21hasmodesteffectsonbodyweighthepaticsteatosisandinsulinresistanceinhighfatfedmice
AT johnatadross combinedgeneticdeletionofgdf15andfgf21hasmodesteffectsonbodyweighthepaticsteatosisandinsulinresistanceinhighfatfedmice
AT jameswarner combinedgeneticdeletionofgdf15andfgf21hasmodesteffectsonbodyweighthepaticsteatosisandinsulinresistanceinhighfatfedmice
AT jamesharrison combinedgeneticdeletionofgdf15andfgf21hasmodesteffectsonbodyweighthepaticsteatosisandinsulinresistanceinhighfatfedmice
AT samuelvirtue combinedgeneticdeletionofgdf15andfgf21hasmodesteffectsonbodyweighthepaticsteatosisandinsulinresistanceinhighfatfedmice
AT fabioscurria combinedgeneticdeletionofgdf15andfgf21hasmodesteffectsonbodyweighthepaticsteatosisandinsulinresistanceinhighfatfedmice
AT ilonazvetkova combinedgeneticdeletionofgdf15andfgf21hasmodesteffectsonbodyweighthepaticsteatosisandinsulinresistanceinhighfatfedmice
AT matthiasbluher combinedgeneticdeletionofgdf15andfgf21hasmodesteffectsonbodyweighthepaticsteatosisandinsulinresistanceinhighfatfedmice
AT kerrinssmall combinedgeneticdeletionofgdf15andfgf21hasmodesteffectsonbodyweighthepaticsteatosisandinsulinresistanceinhighfatfedmice
AT stephenorahilly combinedgeneticdeletionofgdf15andfgf21hasmodesteffectsonbodyweighthepaticsteatosisandinsulinresistanceinhighfatfedmice
AT davidbsavage combinedgeneticdeletionofgdf15andfgf21hasmodesteffectsonbodyweighthepaticsteatosisandinsulinresistanceinhighfatfedmice